Encompass Health (EHC)
(Delayed Data from NYSE)
$123.81 USD
-0.85 (-0.68%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $123.76 -0.05 (-0.04%) 6:14 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/27/2025
Time: -- |
9/2025 | $1.20 | -2.25% |
Earnings Summary
For their last quarter, Encompass Health (EHC) reported earnings of $1.40 per share, beating the Zacks Consensus Estimate of $1.20 per share. This reflects a positive earnings surprise of 16.67%. Look out for EHC's next earnings release expected on October 27, 2025. For the next earning release, we expect the company to report earnings of $1.20 per share, reflecting a year-over-year increase of 16.5%.
Earnings History
Price & Consensus
Zacks News for EHC
Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
EHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Encompass Health Opens New Rehabilitation Hospital in The Villages
Encompass Health Flexes Its Muscle: Margins Widen as Volumes Climb
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
EHC FAQs
Based on past history, Zacks believes Encompass Health Corporation (EHC) will report their next quarter earnings on October 27, 2025. For the next earning release, we expect the company to report earnings of 1.20 per share, reflecting a year-over-year increase of 16.50.
Based on past history, Zacks believes Encompass Health Corporation (EHC) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on October 27, 2025.
The Zacks Consensus Estimate for Encompass Health Corporation (EHC) for the quarter ending in September 2025 is $1.20 a share. We expect Encompass Health Corporation to miss by -2.25%.
In the earnings report for the quarter ending in September 2024, Encompass Health Corporation (EHC) announced earnings of $1.03 per share versus the Zacks Consensus Estimate of $0.94 per share, representing a surprise of 9.57%.